|
PureHealth surpasses AED
6.33 billion in local
procurement spend, nearly
tripling in-country value
contribution
(ABU DHABI)
-
PureHealth,
the largest healthcare group
in the Middle East, today
announced that it has
exceeded AED 6.33 billion in
local procurement spend
since joining the Ministry
of Industry and Advanced
Technology’s (MoIAT)
National In-Country Value
(ICV) program in 2022. This
marks a nearly threefold
increase from AED 2.25
billion in 2025,
underscoring the Group’s
growing role in advancing
the UAE’s economic
diversification and
industrial development.
The milestone was
highlighted during
PureHealth’s participation
at Make it in the Emirates
(MIITE) 2026, where the
Group continues to
demonstrate how sustained
investment in ICV delivers
measurable impact across the
UAE’s healthcare and
industrial landscape.
PureHealth remains on track
to achieve its AED 13
billion ICV commitment by
2032, driven by a scaled,
system-wide approach to
strengthening local supply
chains, supporting national
industries, and enabling
sustainable economic growth.
Rashed
AlQubaisi, Group Chief
Operating Officer of
PureHealth, said:
“Our ICV strategy is central
to how we scale impact
across the healthcare
ecosystem. Surpassing AED
6.33 billion in local
procurement reflects the
scale at which we are
embedding ICV across our
operations, from investing
in local suppliers and
building national
capabilities to enhancing
sourcing, logistics, and
delivery. By consistently
prioritizing local
capability, we are
strengthening supply chain
resilience, safeguarding
continuity of care, and
aligning with the UAE’s
industrial agenda while
contributing to long-term
economic growth and
diversification.”
PureHealth is delivering
strong ICV performance
across its ecosystem,
underpinned by a
coordinated, system-wide
approach. SEHA leads with an
ICV score of 81.13%,
alongside solid
contributions from Sheikh
Shakhbout Medical City
(SSMC), Daman, PureLab, and
Rafed. Collectively,
PureHealth’s entities
demonstrate how localization
can be effectively embedded
across procurement,
operations, and workforce
development.
This
impact has been recognized
at a national level. In
2026, SEHA was awarded the
ICV Champion Award at Make
it in the Emirates, and in
2025, Rafed was awarded the
same award for its role in
advancing SME participation
through the In-Country Value
program. Daman also received
three awards from the
federal Emiratization
initiative, Nafis, including
first place for “Efforts
Supporting Emiratization”
and a Diamond Category award
for staff empowerment.
PureHealth’s procurement
strategy spans medical
supplies, pharmaceuticals,
technology, and
infrastructure, with a clear
focus on UAE-based suppliers
that meet global standards.
Through long-term
partnerships and targeted
supplier development
programs, the Group is
expanding opportunities for
local businesses while
strengthening supply chain
resilience.
As the
UAE accelerates its
industrial ambitions,
PureHealth’s ongoing
investment in ICV positions
the Group as a key enabler
of sustainable economic
growth, demonstrating how
healthcare delivery can
directly contribute to
national development
priorities.
PRINT
THIS ARTICLE
|
